12 research outputs found
Lessons Learned from Web and Social Media Based Educational Initiatives By Pulmonary, Critical Care & Sleep Societies
Pediatric Critical Care and COVID-19
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, disproportionally affects adults (children 60 centers in nearly 20 countries from the Americas and Europe. In this report, we provide preliminary insights into our first 17 patients.
Methods
The Critical Coronavirus and Kids Epidemiology is a cohort study of children <19 years old with severe or critical COVID-19. The study period runs from April through December 2020. For this report, we included patients enrolled through April 23.
We defined critical COVID-19 as a positive severe acute respiratory syndrome coronavirus 2 test result and requiring ICU therapies (high-flow nasal cannula [HFNC], noninvasive ventilation [NIV], invasive mechanical ventilation [IMV], vasoactive support, continuous renal replacement therapy). Severe COVID-19 included those receiving mask or nasal oxygen exceeding the pediatric acute respiratory distress syndrome (ARDS) “at risk” threshold.8
Deidentified data were collected by using a modification of the International Severe Acute Respiratory and Emerging Infection Consortium form (https://isaric.tghn.org/COVID-19-CRF/). Local ethics approval was obtained with a waiver of need for consent.
Results
We enrolled 17 children from 10 PICUs in Chile, Colombia, Italy, Spain, and the United States. Detailed data are in the Supplemental Information. Most patients were male (65%), young (median 4 years; range 0.08–18 years), and without known COVID-19 exposure (14 of 17). Comorbidities (Table 1, Supplemental Table 3) were common (71%) but variable. Symptoms were heterogenous, with fever and cough being most frequent (Table 1, Supplemental Table 3). Most with gastrointestinal (GI) symptoms (4 of 6) were also diagnosed with myocarditis (Supplemental Table 4). All these were from Europe and without previous cardiovascular disease
Prevalence of Errors in Anaphylaxis in Kids (PEAK): A Multicenter Simulation-Based Study
Background
Multi-institutional, international practice variation of pediatric anaphylaxis management by health care providers has not been reported.
Objective
To characterize variability in epinephrine administration for pediatric anaphylaxis across institutions, including frequency and types of medication errors.
Methods
A prospective, observational, study using a standardized in situ simulated anaphylaxis scenario was performed across 28 health care institutions in 6 countries. The on-duty health care team was called for a child (patient simulator) in anaphylaxis. Real medications and supplies were obtained from their actual locations. Demographic data about team members, institutional protocols for anaphylaxis, timing of epinephrine delivery, medication errors, and systems safety issues discovered during the simulation were collected.
Results
Thirty-seven in situ simulations were performed. Anaphylaxis guidelines existed in 41% (15 of 37) of institutions. Teams used a cognitive aid for medication dosing 41% (15 of 37) of the time and 32% (12 of 37) for preparation. Epinephrine autoinjectors were not available in 54% (20 of 37) of institutions and were used in only 14% (5 of 37) of simulations. Median time to epinephrine administration was 95 seconds (interquartile range, 77-252) for epinephrine autoinjector and 263 seconds (interquartile range, 146-407.5) for manually prepared epinephrine (P = .12). At least 1 medication error occurred in 68% (25 of 37) of simulations. Nursing experience with epinephrine administration for anaphylaxis was associated with fewer preparation (P = .04) and administration (P = .01) errors. Latent safety threats were reported by 30% (11 of 37) of institutions, and more than half of these (6 of 11) involved a cognitive aid.
Conclusions
A multicenter, international study of simulated pediatric anaphylaxis reveals (1) variation in management between institutions in the use of protocols, cognitive aids, and medication formularies, (2) frequent errors involving epinephrine, and (3) latent safety threats related to cognitive aids among multiple sites
Lessons learned from web- and social media- based educational initiatives by pulmonary, critical care and sleep societies
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.Importance Coronavirus disease 2019 (COVID-19) affects the nervous system in adult patients. The spectrum of neurologic involvement in children and adolescents is unclear.
Objective To understand the range and severity of neurologic involvement among children and adolescents associated with COVID-19.
Setting, Design, and Participants Case series of patients (age <21 years) hospitalized between March 15, 2020, and December 15, 2020, with positive severe acute respiratory syndrome coronavirus 2 test result (reverse transcriptase-polymerase chain reaction and/or antibody) at 61 US hospitals in the Overcoming COVID-19 public health registry, including 616 (36%) meeting criteria for multisystem inflammatory syndrome in children. Patients with neurologic involvement had acute neurologic signs, symptoms, or diseases on presentation or during hospitalization. Life-threatening involvement was adjudicated by experts based on clinical and/or neuroradiologic features.
Exposures Severe acute respiratory syndrome coronavirus 2.
Main Outcomes and Measures Type and severity of neurologic involvement, laboratory and imaging data, and outcomes (death or survival with new neurologic deficits) at hospital discharge.
Results Of 1695 patients (909 [54%] male; median [interquartile range] age, 9.1 [2.4-15.3] years), 365 (22%) from 52 sites had documented neurologic involvement. Patients with neurologic involvement were more likely to have underlying neurologic disorders (81 of 365 [22%]) compared with those without (113 of 1330 [8%]), but a similar number were previously healthy (195 [53%] vs 723 [54%]) and met criteria for multisystem inflammatory syndrome in children (126 [35%] vs 490 [37%]). Among those with neurologic involvement, 322 (88%) had transient symptoms and survived, and 43 (12%) developed life-threatening conditions clinically adjudicated to be associated with COVID-19, including severe encephalopathy (n = 15; 5 with splenial lesions), stroke (n = 12), central nervous system infection/demyelination (n = 8), Guillain-Barré syndrome/variants (n = 4), and acute fulminant cerebral edema (n = 4). Compared with those without life-threatening conditions (n = 322), those with life-threatening neurologic conditions had higher neutrophil-to-lymphocyte ratios (median, 12.2 vs 4.4) and higher reported frequency of D-dimer greater than 3 μg/mL fibrinogen equivalent units (21 [49%] vs 72 [22%]). Of 43 patients who developed COVID-19–related life-threatening neurologic involvement, 17 survivors (40%) had new neurologic deficits at hospital discharge, and 11 patients (26%) died.
Conclusions and Relevance In this study, many children and adolescents hospitalized for COVID-19 or multisystem inflammatory syndrome in children had neurologic involvement, mostly transient symptoms. A range of life-threatening and fatal neurologic conditions associated with COVID-19 infrequently occurred. Effects on long-term neurodevelopmental outcomes are unknown
Effect of educational and electronic medical record interventions on food allergy management
Improving multidisciplinary involvement at the critical care congress through social media
Learning Objectives: The Society of Critical Care Medicine promotes a collaborative multidisciplinary practice, with a team consisting of professionals in different fields. Participation in social media activities, such as live-tweeting a meeting provides a unique opportunity for members of all professions to participate, and may allow for inclusion of a more diverse group in discussions. We assessed participation using social media metrics by physicians and non-physicians in conversations at the annual Critical Care Congress (CCC).
Methods: Symplur Analytics were used to compare the characteristics of those who tweeted using the 2015 and 2016 CCC hashtag (#CCC44 and #CCC45, respectively). Characteristics of the top 50 participants during the conference were compared. Allied health professionals (AHP) were defined as non-physician healthcare providers.
Results: There was an increase in tweets and participants from 2015 (4,374 tweets, 625 participants) to 2016 (14,358 tweets, 1,693 participants). In 2015, 27 of the top 50 tweeters were physicians, 7 were AHP (2 nurses, 2 advanced practitioners, and 1 pharmacist), 10 were organizations, and 6 were other non-healthcare individuals. In 2016, 22 of the top 50 tweeters were physicians, 17 were AHP (2 nurses, 5 advanced practitioners, 5 pharmacists, 2 dietitians, and 3 other providers), 8 were organizations, and 3 were other non-healthcare individuals. There were significantly more AHP participating in social media during 2016 CCC compared to 2015 (34% vs 14% of the top 50 accounts; p=0.047). The number of followers of AHP accounts were significantly fewer than the number of followers of the physician accounts (800 ± 626 followers vs 1,608 ± 2,282 followers; p=0.02), but there was no significant difference in number of tweets (7,403 ± 8,993 vs 16,764 ± 36,230 tweets; p=0.1) or duration of time on Twitter (4.8 ± 2.3 vs 5.1 ± 2.1 yrs; p=0.6).
Conclusions: Social media is another way to engage all heath care professionals in academic conversations that occur during CCC. More effort should be made to increase inclusion in this important venue for multidisciplinary conversation
Use of session-specific hashtags to enhance the reach of the critical care congress in social media
Recommended from our members
Adenoviral Respiratory Infection-Associated Mortality in Children: A Retrospective Case Series.
Viral respiratory infections are a leading cause of illness and hospitalization in young children worldwide. Case fatality rates in pediatric patients with adenoviral lower respiratory tract infection requiring intensive care unit (ICU) admission have been reported between 7 and 22%. We investigated the demographics and clinical characteristics in pediatric mortalities associated with adenoviral respiratory infection at 12 academic childrens hospitals in the United States. There were 107 mortality cases included in our study, 73% of which had a chronic medical condition. The most common chronic medical condition was immunocompromised state in 37 cases (35%). The incidences of pediatric acute respiratory distress syndrome (78%) and multiple organ dysfunction syndrome (94%) were profound. Immunocompetent cases were more likely to receive mechanical ventilation within the first hour of ICU admission (60 vs. 14%, p  < 0.001) and extracorporeal membrane oxygenation (27 vs. 5%, p  = 0.009), and less likely to receive continuous renal replacement therapy (20 vs. 49%, p  = 0.002) or have renal dysfunction (54 vs. 78%, p  = 0.014) as compared with immunocompromised cases. Immunocompromised cases were more likely to have bacteremia (57 vs. 16%, p  < 0.001) and adenoviremia (51 vs. 17%, p  < 0.001) and be treated with antiviral medications (81 vs. 26%, p  < 0.001). We observed a high burden of nonrespiratory organ system dysfunction in a cohort of pediatric case fatalities with adenoviral respiratory infection. The majority of cases had a chronic medical condition associated with an increased risk of complications from viral respiratory illness, most notably immunocompromised state. Important treatment differences were noted between immunocompromised and immunocompetent cases